Encompass Health (EHC)
(Delayed Data from NYSE)
$92.65 USD
+0.59 (0.64%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $92.69 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 104 | 53 | 120 | 289 | 152 |
Receivables | 612 | 537 | 680 | 573 | 506 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 126 | 127 | 121 | 86 | 98 |
Total Current Assets | 842 | 717 | 921 | 949 | 756 |
Net Property & Equipment | 3,301 | 2,939 | 2,602 | 2,207 | 1,959 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 3 |
Intangibles | 1,560 | 1,546 | 2,845 | 2,750 | 2,782 |
Deposits & Other Assets | 192 | 222 | 255 | 295 | 305 |
Total Assets | 6,102 | 5,637 | 6,865 | 6,446 | 6,081 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 170 | 133 | 138 | 115 | 95 |
Current Portion Long-Term Debt | 25 | 25 | 43 | 38 | 39 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 250 | 211 | 310 | 301 | 243 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 212 | 207 | 220 | 218 | 304 |
Total Current Liabilities | 656 | 576 | 749 | 717 | 721 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 87 | 83 | 87 | 52 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,688 | 2,742 | 3,244 | 3,251 | 3,023 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 178 | 174 | 173 | 215 | 160 |
Minority Interest (Liabilities) | 42 | 36 | 42 | 32 | 240 |
Total Liabilities | 3,847 | 3,810 | 4,508 | 4,476 | 4,388 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 1,787 | 1,730 | 2,290 | 2,327 | 2,370 |
Retained Earnings | 0 | 0 | 142 | -242 | -527 |
Other Equity | 1,014 | 632 | 446 | 382 | 341 |
Treasury Stock | 547 | 537 | 521 | 497 | 492 |
Total Shareholder's Equity | 2,255 | 1,826 | 2,357 | 1,970 | 1,693 |
Total Liabilities & Shareholder's Equity | 6,102 | 5,637 | 6,865 | 6,446 | 6,081 |
Total Common Equity | 2,255 | 1,826 | 2,357 | 1,970 | 1,693 |
Shares Outstanding | 100.20 | 99.70 | 99.40 | 99.40 | 98.60 |
Book Value Per Share | 22.51 | 18.32 | 23.71 | 19.82 | 17.17 |
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 182 | 173 | 104 | 141 | 154 |
Receivables | 590 | 619 | 612 | 536 | 532 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 166 | 138 | 126 | 137 | 138 |
Total Current Assets | 938 | 930 | 842 | 814 | 824 |
Net Property & Equipment | 3,439 | 3,370 | 3,301 | 3,186 | 3,062 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,587 | 1,554 | 1,560 | 1,558 | 1,549 |
Deposits & Other Assets | 208 | 179 | 192 | 210 | 220 |
Total Assets | 6,389 | 6,231 | 6,102 | 5,964 | 5,861 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 164 | 166 | 170 | 165 | 156 |
Current Portion Long-Term Debt | 33 | 26 | 25 | 24 | 23 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 471 | 463 | 250 | 425 | 450 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 212 | 0 | 0 |
Total Current Liabilities | 695 | 680 | 656 | 639 | 655 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 91 | 94 | 87 | 80 | 83 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,684 | 2,683 | 2,688 | 2,693 | 2,698 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 187 | 178 | 179 | 176 | |
Minority Interest (Liabilities) | 49 | 41 | 42 | 42 | 39 |
Total Liabilities | 3,907 | 3,869 | 3,847 | 3,817 | 3,843 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 1,807 | 1,797 | 1,787 | 1,772 | 1,755 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 |
Other Equity | 1,244 | 1,124 | 1,014 | 922 | 807 |
Treasury Stock | 571 | 560 | 547 | 547 | 546 |
Total Shareholder's Equity | 2,481 | 2,362 | 2,255 | 2,148 | 2,018 |
Total Liabilities & Shareholder's Equity | 6,389 | 6,231 | 6,102 | 5,964 | 5,861 |
Total Common Equity | 2,481 | 2,362 | 2,255 | 2,148 | 2,018 |
Shares Outstanding | 100.60 | 100.60 | 100.20 | 100.20 | 100.20 |
Book Value Per Share | 24.67 | 23.48 | 22.51 | 21.43 | 20.14 |